411 related articles for article (PubMed ID: 12698083)
1. Effects of ursodeoxycholic acid (ursodiol) treatment on chronic viral hepatitis in heart transplant patients: results of a prospective, double-blind, placebo-randomized study.
Cadranel JF; Di Martino V; Dorent R; Bernard B; Hoang C; Myara A; Pauwels A; Ghoussoub JJ; Perrin M; Grippon P; Thabut D; Trivin F; Huraux JM; Gandjbakhch I; Opolon P; Lunel F
Transplantation; 2003 Apr; 75(7):977-82. PubMed ID: 12698083
[TBL] [Abstract][Full Text] [Related]
2. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group.
Poupon RE; Balkau B; Eschwège E; Poupon R
N Engl J Med; 1991 May; 324(22):1548-54. PubMed ID: 1674105
[TBL] [Abstract][Full Text] [Related]
3. Effects of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis: a dose-response study.
Crosignani A; Battezzati PM; Setchell KD; Camisasca M; Bertolini E; Roda A; Zuin M; Podda M
Hepatology; 1991 Feb; 13(2):339-44. PubMed ID: 1671665
[TBL] [Abstract][Full Text] [Related]
4. A multicenter randomized controlled dose study of ursodeoxycholic acid for chronic hepatitis C.
Takano S; Ito Y; Yokosuka O; Ohto M; Uchiumi K; Hirota K; Omata M
Hepatology; 1994 Sep; 20(3):558-64. PubMed ID: 7521313
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of diphenyl-dimethyl-dicarboxylate plus garlic oil in patients with chronic hepatitis.
Lee MH; Kim YM; Kim SG
Int J Clin Pharmacol Ther; 2012 Nov; 50(11):778-86. PubMed ID: 22943930
[TBL] [Abstract][Full Text] [Related]
6. A large-scale, multicentre, double-blind trial of ursodeoxycholic acid in patients with chronic hepatitis C.
Omata M; Yoshida H; Toyota J; Tomita E; Nishiguchi S; Hayashi N; Iino S; Makino I; Okita K; Toda G; Tanikawa K; Kumada H;
Gut; 2007 Dec; 56(12):1747-53. PubMed ID: 17573387
[TBL] [Abstract][Full Text] [Related]
7. Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Belgian-Dutch PSC Study Group.
van Hoogstraten HJ; Vleggaar FP; Boland GJ; van Steenbergen W; Griffioen P; Hop WC; van Hattum J; van Berge Henegouwen GP; Schalm SW; van Buuren HR
Am J Gastroenterol; 2000 Aug; 95(8):2015-22. PubMed ID: 10950051
[TBL] [Abstract][Full Text] [Related]
8. Tauroursodeoxycholic acid for the treatment of HCV-related chronic hepatitis: a multicenter placebo-controlled study.
Crosignani A; Budillon G; Cimino L; Del Vecchio Blanco C; Loguercio C; Ideo G; Raimondo G; Stabilini R; Podda M
Hepatogastroenterology; 1998; 45(23):1624-9. PubMed ID: 9840118
[TBL] [Abstract][Full Text] [Related]
9. High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study.
Olsson R; Boberg KM; de Muckadell OS; Lindgren S; Hultcrantz R; Folvik G; Bell H; Gangsøy-Kristiansen M; Matre J; Rydning A; Wikman O; Danielsson A; Sandberg-Gertzén H; Ung KA; Eriksson A; Lööf L; Prytz H; Marschall HU; Broomé U
Gastroenterology; 2005 Nov; 129(5):1464-72. PubMed ID: 16285948
[TBL] [Abstract][Full Text] [Related]
10. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
Tarao K; Fujiyama S; Ohkawa S; Miyakawa K; Tamai S; Hirokawa S; Masaki T; Tanaka K
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):164-9. PubMed ID: 15668491
[TBL] [Abstract][Full Text] [Related]
11. Combined ursodeoxycholic acid and glycyrrhizin therapy for chronic hepatitis C virus infection: a randomized controlled trial in 170 patients.
Tsubota A; Kumada H; Arase Y; Chayama K; Saitoh S; Ikeda K; Kobayashi M; Suzuki Y; Murashima N
Eur J Gastroenterol Hepatol; 1999 Oct; 11(10):1077-83. PubMed ID: 10524635
[TBL] [Abstract][Full Text] [Related]
12. A double-blind placebo-controlled study of emtricitabine in chronic hepatitis B.
Lim SG; Ng TM; Kung N; Krastev Z; Volfova M; Husa P; Lee SS; Chan S; Shiffman ML; Washington MK; Rigney A; Anderson J; Mondou E; Snow A; Sorbel J; Guan R; Rousseau F;
Arch Intern Med; 2006 Jan; 166(1):49-56. PubMed ID: 16401810
[TBL] [Abstract][Full Text] [Related]
13. Two-year lamivudine treatment for hepatitis B e antigen-negative chronic hepatitis B: a double-blind, placebo-controlled trial.
Chan HL; Wang H; Niu J; Chim AM; Sung JJ
Antivir Ther; 2007; 12(3):345-53. PubMed ID: 17591024
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis.
Combes B; Carithers RL; Maddrey WC; Lin D; McDonald MF; Wheeler DE; Eigenbrodt EH; Muñoz SJ; Rubin R; Garcia-Tsao G
Hepatology; 1995 Sep; 22(3):759-66. PubMed ID: 7657280
[TBL] [Abstract][Full Text] [Related]
15. A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomized, controlled trial in Japan.
Yano M; Hayashi H; Yoshioka K; Kohgo Y; Saito H; Niitsu Y; Kato J; Iino S; Yotsuyanagi H; Kobayashi Y; Kawamura K; Kakumu S; Kaito M; Ikoma J; Wakusawa S; Okanoue T; Sumida Y; Kimura F; Kajiwara E; Sata M; Ogata K
J Gastroenterol; 2004 Jun; 39(6):570-4. PubMed ID: 15235875
[TBL] [Abstract][Full Text] [Related]
16. Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial.
Czaja AJ; Carpenter HA; Lindor KD
Hepatology; 1999 Dec; 30(6):1381-6. PubMed ID: 10573515
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial.
Lindor KD; Kowdley KV; Heathcote EJ; Harrison ME; Jorgensen R; Angulo P; Lymp JF; Burgart L; Colin P
Hepatology; 2004 Mar; 39(3):770-8. PubMed ID: 14999696
[TBL] [Abstract][Full Text] [Related]
18. [Computerized histological analysis in chronic viral hepatitis].
Hassan C; Tavani PD; Serafini B
Pathologica; 1999 Jun; 91(3):173-8. PubMed ID: 10536462
[TBL] [Abstract][Full Text] [Related]
19. Effects of ursodeoxycholic acid on serum liver enzymes in patients with hepatitis C virus-related chronic liver disease.
Puoti C; Magrini A; Filippi T; Annovazzi G; Pannullo A
Eur J Gastroenterol Hepatol; 1995 Feb; 7(2):151-4. PubMed ID: 7712308
[TBL] [Abstract][Full Text] [Related]
20. Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis?
Vardar R; Vardar E; Demiri S; Sayhan SE; Bayol U; Yildiz C; Postaci H
Hepatogastroenterology; 2009; 56(94-95):1459-65. PubMed ID: 19950810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
